Related Experiment Video
Updated: Jul 12, 2026

Bedside Ultrasound for Guiding Fluid Removal in Patients with Pulmonary Edema: The Reverse-FALLS Protocol
Published on: July 28, 2018
Optimal use of diuretics in patients with heart failure
Jigar Patel1, Michael Smith, J Thomas Heywood
1Scripps Clinic, Department of Cardiology, Mailstop: SW206, 10666 North Torrey Pines Road, La Jolla, CA 92037, USA.
Insights
Diuretics are essential for managing fluid overload in heart failure (HF) but lack large trials. Use the lowest effective dose and discontinue when possible, especially with neurohormonal blockade.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Diuretics are the primary treatment for fluid overload in decompensated heart failure (HF).
- Despite widespread use, diuretics are not supported by large randomized clinical trials.
- Their use is considered more art than science due to a lack of definitive evidence.
Purpose of the Study:
- To review the current understanding of diuretic use in heart failure.
- To highlight the benefits and drawbacks of diuretic therapy in HF management.
- To provide guidance on optimal diuretic dosing and discontinuation strategies.
Main Methods:
- Literature review of current practices and evidence regarding diuretics in HF.
- Analysis of potential adverse effects and benefits of diuretic therapy.
- Discussion of alternative management strategies for HF patients.
Main Results:
- Diuretics effectively relieve congestion in decompensated HF.
- Potential drawbacks include electrolyte imbalances, neurohormonal activation, hypovolemia, and renal dysfunction.
- Many HF outpatients can be managed without diuretics once on optimal neurohormonal blockade.
Conclusions:
- The lowest effective dose of diuretics should be used to achieve euvolemia.
- Discontinuation of diuretics should be considered when feasible.
- Optimizing neurohormonal blockade may allow for diuretic-free management in some HF patients.
Abstract:
Currently, the use of diuretics in heart failure (HF) remains more of an art than a science. Diuretics are the principle means for relieving congestion in patients with decompensated HF. Unfortunately, they persist as the only major therapy in HF that has not been subjected to a large randomized clinical trial, precisely because no comparable therapy exists that can so easily, efficiently, and inexpensively treat fluid overload. Nonetheless, diuretics have many potential drawbacks, including electrolyte abnormalities, neurohormonal activation, hypovolemia, renal dysfunction, and direct myocardial effects. Until definitive answers about mortality are settled, the lowest dose of a diuretic that can produce euvolemia should be employed and these agents should be discontinued when possible. Many outpatients with HF can be managed quite well without diuretics once adequate neurohormonal blockade with angiotensin-converting enzyme inhibitors and beta blockers has been achieved.
Related Concept Videos
Heart Failure Drugs: Diuretics
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure Drugs: β-Blockers
